|
🐜
|
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.
16 auth.
D. McGrail,
P. Pilié,
N. Rashid,
L. Voorwerk,
M. Slagter,
M. Kok,
E. Jonasch,
M. Khasraw,
A. Heimberger,
B. Lim,
...
N. Ueno,
J. Litton,
R. Ferrarotto,
J. T. Chang,
S. Moulder,
S-Y Lin
|
9 |
2021 |
9
🐜
|
|
🦁
|
Inflammatory breast cancer biology: the tumour microenvironment is key
B. Lim,
W. Woodward,
Xiaoping Wang,
J. Reuben,
N. Ueno
|
7 |
2018 |
7
🦁
|
|
🦁
|
Advancing Cancer Research and Medicine with Single-Cell Genomics.
B. Lim,
Yiyun Lin,
N. Navin
|
7 |
2020 |
7
🦁
|
|
🐬
|
Androgen Receptor Function and Androgen Receptor–Targeted Therapies in Breast Cancer: A Review
M. Kono,
T. Fujii,
B. Lim,
M. Karuturi,
D. Tripathy,
N. Ueno
|
7 |
2017 |
7
🐬
|
|
🐜
|
A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus
10 auth.
Yanchun Ma,
S. Hao,
Shuwen Wang,
Yuanjun Zhao,
B. Lim,
M. Lei,
...
D. Spector,
W. El-Deiry,
Si-Yang Zheng,
Jiyue Zhu
|
7 |
2015 |
7
🐜
|
|
🐜
|
Breast Tumors Maintain a Reservoir of Subclonal Diversity During Expansion
26 auth.
Darlan C Minussi,
Michael D. Nicholson,
Hanghui Ye,
Alexander Davis,
Kaile Wang,
Toby M. Baker,
M. Tarabichi,
Emi Sei,
Mashiat Rabbani,
C. Peng,
Min Hu,
S. Bai,
Yu-Wei Lin,
Aislyn Schalck,
A. Multani,
...
Jin Ma,
Thomas O. McDonald,
Anna K. Casasent,
A. Barrera,
Hui Chen,
B. Lim,
B. Arun,
F. Meric-Bernstam,
P. Van Loo,
F. Michor,
N. Navin
|
7 |
2021 |
7
🐜
|
|
🐜
|
Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis
12 auth.
Peishan Li,
Ming Lu,
Jiayuan Shi,
Zheng Gong,
Li Hua,
Qing Li,
...
B. Lim,
X. Zhang,
Xiaowen Chen,
Sheng Li,
L. Shultz,
G. Ren
|
7 |
2020 |
7
🐜
|
|
🐢
|
Targeting Apoptosis in Cancer
Puneet Singh,
B. Lim
|
7 |
2022 |
7
🐢
|
|
🐜
|
Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer
13 auth.
T. Fujii,
T. Kogawa,
W. Dong,
A. Sahin,
S. Moulder,
J. Litton,
D. Tripathy,
T. Iwamoto,
K. Hunt,
L. Pusztai,
...
B. Lim,
Y. Shen,
N. Ueno
|
6 |
2017 |
6
🐜
|
|
🐜
|
Discovery and clinical introduction of first-in-class imipridone ONC201
32 auth.
J. Allen,
C. L. Kline,
V. Prabhu,
Jessica Wagner,
J. Ishizawa,
Neel S. Madhukar,
Avital Lev,
M. Baumeister,
Lanlan Zhou,
Amriti R Lulla,
M. Stogniew,
L. Schalop,
C. Benes,
H. Kaufman,
R. Pottorf,
...
B. R. Nallaganchu,
G. Olson,
F. Al-Mulla,
M. Duvic,
Gen Sheng Wu,
D. Dicker,
Mala K. Talekar,
B. Lim,
O. Elemento,
W. Oster,
J. Bertino,
K. Flaherty,
Michael L. Wang,
G. Borthakur,
M. Andreeff,
M. Stein,
W. El-Deiry
|
6 |
2016 |
6
🐜
|
|
🐜
|
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
21 auth.
R. Soundararajan,
Jared J. Fradette,
J. Konen,
S. Moulder,
X. Zhang,
D. Gibbons,
N. Varadarajan,
I. Wistuba,
D. Tripathy,
C. Bernatchez,
...
L. Byers,
Jeffrey T. Chang,
A. Contreras,
B. Lim,
E. Parra,
Emily B. Roarty,
Jing Wang,
Fei Yang,
M. Barton,
J. Rosen,
Sendurai A Mani
|
6 |
2019 |
6
🐜
|
